|
|
||||||||
1
Department of Gastroenterology and Hepatology, Kinki University School of
Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.
2
Present address: Department of Ultrasound, Zhongshan Hospital, Shanghai
Medical University, 180 Fenglin Rd., Shanghai, 200032, China.
3
Section of Abdominal Ultrasound, Kinki University School of Medicine, Osaka
589-8511, Japan.
OBJECTIVE. Our objective was to assess the usefulness of contrast-enhanced subtraction harmonic sonography in evaluating the treatment response of patients with hepatocellular carcinoma.
SUBJECTS AND METHODS. Thirty-two hepatocellular carcinoma lesions in 26 patients (age range, 44-85 years; mean age, 66 years) were examined with Levovist-enhanced intermittent harmonic imaging before and after therapy. A Toshiba Powervision 8000 was used. A subtraction image was obtained by digitally subtracting the last-frame harmonic image from the first-frame image when multishot mode was preset. Results of contrast-enhanced CT were compared with the results of subtraction harmonic imaging.
RESULTS. Before therapy, an enhancement pattern of tumor vascularity was seen for 93.8% (30/32) of hepatocellular carcinoma nodules on subtraction harmonic imaging. After therapy, subtraction harmonic imaging showed 46.7% (14/30) enhancement (incomplete tumor necrosis) and 53.3% (16/30) no enhancement (complete tumor necrosis). When dynamic CT was the gold standard, the sensitivity, specificity, and accuracy of subtraction harmonic imaging were 93.3%, 100%, and 96.7%, respectively. Intratumoral flow signals in hepatocellular carcinoma after therapy on harmonic imaging were used as a guide to target additional percutaneous therapy.
CONCLUSION. Digital subtraction contrast-enhanced harmonic imaging can depict tumor vascularity in hepatocellular carcinoma after therapy sensitively and accurately. Because it is easy to perform and provides real-time needle insertion guidance, it may be preferable to perform after localized therapy to monitor treatment response, which will reduce unnecessary CT scanning.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Shao, J. Bai, L. Cui, J. Wang, Y. Fu, K. Liu, and S. Feng Elastographic Evaluation of the Temporal Formation of Ethanol-Induced Hepatic Lesions: Preliminary In Vitro Results J. Ultrasound Med., September 1, 2007; 26(9): 1191 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wu, M.-H. Chen, S.-S. Yin, K. Yan, Z.-H. Fan, W. Yang, Y. Dai, L. Huo, and J.-Y. Li The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. Am. J. Roentgenol., September 1, 2006; 187(3): 752 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kim, T. K. Kim, P. N. Kim, A. Y. Kim, E. Y. Ko, K. W. Kim, K.-B. Sung, H. K. Ha, H. C. Kim, and M.-G. Lee Assessment of the Therapeutic Response of Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization: Comparison of Contrast-Enhanced Sonography and 3-Phase Computed Tomography J. Ultrasound Med., April 1, 2006; 25(4): 477 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Q Zheng and M Kudo Hepatic angiomyolipoma: identification of an efferent vessel to be hepatic vein by contrast-enhanced harmonic ultrasound Br. J. Radiol., October 1, 2005; 78(934): 956 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Catalano and A. Siani Peripheral Arterioportal Fistula: Demonstration With Contrast-Enhanced Sonography J. Ultrasound Med., July 1, 2005; 24(7): 1027 - 1030. [Full Text] [PDF] |
||||
![]() |
H. Ding, W.-P. Wang, B.-J. Huang, R.-X. Wei, N.-A. He, Q. Qi, and C.-L. Li Imaging of Focal Liver Lesions: Low-Mechanical-Index Real-time Ultrasonography With SonoVue J. Ultrasound Med., March 1, 2005; 24(3): 285 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Minami, M. Kudo, T. Kawasaki, H. Chung, C. Ogawa, and H. Shiozaki Treatment of Hepatocellular Carcinoma with Percutaneous Radiofrequency Ablation: Usefulness of Contrast Harmonic Sonography for Lesions Poorly Defined with B-Mode Sonography Am. J. Roentgenol., July 1, 2004; 183(1): 153 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kitano, M Kudo, K Maekawa, Y Suetomi, H Sakamoto, N Fukuta, R Nakaoka, and T Kawasaki Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography Gut, June 1, 2004; 53(6): 854 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Isozaki, K. Numata, T. Kiba, K. Hara, M. Morimoto, T. Sakaguchi, H. Sekihara, T. Kubota, H. Shimada, T. Morizane, et al. Differential Diagnosis of Hepatic Tumors by Using Contrast Enhancement Patterns at US Radiology, December 1, 2003; 229(3): 798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Wen, M. Kudo, R. Q. Zheng, Y. Minami, H. Chung, Y. Suetomi, H. Onda, M. Kitano, T. Kawasaki, and K. Maekawa Radiofrequency Ablation of Hepatocellular Carcinoma: Therapeutic Response Using Contrast-Enhanced Coded Phase-Inversion Harmonic Sonography Am. J. Roentgenol., July 1, 2003; 181(1): 57 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Furuse, M Nagase, H Ishii, and M Yoshino Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions Br. J. Radiol., June 1, 2003; 76(906): 385 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Minami, M. Kudo, T. Kawasaki, M. Kitano, H. Chung, K. Maekawa, and H. Shiozaki Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Usefulness of Coded Phase-Inversion Harmonic Sonography Am. J. Roentgenol., March 1, 2003; 180(3): 703 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Numata, T. Isozaki, Y. Ozawa, T. Sakaguchi, T. Kiba, T. Kubota, A. Ito, K. Sugimori, K. Shirato, M. Morimoto, et al. Percutaneous Ablation Therapy Guided by Contrast-Enhanced Sonography for Patients with Hepatocellular Carcinoma Am. J. Roentgenol., January 1, 2003; 180(1): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hayashi, O. Matsui, K. Ueda, Y. Kawamori, T. Gabata, and M. Kadoya Progression to Hypervascular Hepatocellular Carcinoma: Correlation with Intranodular Blood Supply Evaluated with CT during Intraarterial Injection of Contrast Material Radiology, October 1, 2002; 225(1): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Leyendecker, G. D. Dodd III, G. A. Halff, V. A. McCoy, D. H. Napier, L. G. Hubbard, K. N. Chintapalli, S. Chopra, W. K. Washburn, R. M. Esterl, et al. Sonographically Observed Echogenic Response During Intraoperative Radiofrequency Ablation of Cirrhotic Livers: Pathologic Correlation Am. J. Roentgenol., May 1, 2002; 178(5): 1147 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Choi, H. K. Lim, S. H. Kim, W. J. Lee, H.-J. Jang, H. Kim, S. J. Lee, and J. H. Lim Assessment of Therapeutic Response in Hepatocellular Carcinoma Treated With Percutaneous Radio Frequency Ablation: Comparison of Multiphase Helical Computed Tomography and Power Doppler Ultrasonography With a Microbubble Contrast Agent J. Ultrasound Med., April 1, 2002; 21(4): 391 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rhim, S. N. Goldberg, G. D. Dodd III, L. Solbiati, H. K. Lim, M. Tonolini, and O. K. Cho Essential Techniques for Successful Radio-frequency Thermal Ablation of Malignant Hepatic Tumors RadioGraphics, October 1, 2001; 21(90001): S17 - 35. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |